I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kawanishi, Masafumi
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (30)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Population Pharmacokinetics of Ozoralizumab in Patients wit..:
Takeuchi, Tsutomu
;
Chino, Yukihiro
;
Mano, Yoko
...
The Journal of Clinical Pharmacology. 64 (2023) 4 - p. 418-427 , 2023
Link:
https://doi.org/10.1002/..
?
2
Effect of the extended dosing interval of anti-TNF-α NANOBO..:
Takeuchi, Tsutomu
;
Nakanishi, Megumi
;
Kawanishi, Masafumi
..
Modern Rheumatology. 34 (2023) 4 - p. 678-685 , 2023
Link:
https://doi.org/10.1093/..
?
3
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:
Takeuchi, Tsutomu
;
Chino, Yukihiro
;
Kawanishi, Masafumi
...
Arthritis Research & Therapy. 25 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
4
Efficacy and safety of anti-TNF multivalent NANOBODY® compo..:
Tanaka, Yoshiya
;
Kawanishi, Masafumi
;
Nakanishi, Megumi
..
Modern Rheumatology. 33 (2022) 5 - p. 875-882 , 2022
Link:
https://doi.org/10.1093/..
?
5
Efficacy and safety of the anti-TNF multivalent NANOBODY® c..:
Tanaka, Yoshiya
;
Kawanishi, Masafumi
;
Nakanishi, Megumi
..
Modern Rheumatology. 33 (2022) 5 - p. 883-890 , 2022
Link:
https://doi.org/10.1093/..
?
6
Phase II/III Results of a Trial of Anti–Tumor Necrosis Fact..:
Takeuchi, Tsutomu
;
Kawanishi, Masafumi
;
Nakanishi, Megumi
..
Arthritis & Rheumatology. 74 (2022) 11 - p. 1776-1785 , 2022
Link:
https://doi.org/10.1002/..
?
7
NT-702 (parogrelil hydrochloride, NM-702), a novel and pote..:
Hori, Miyuki
;
Iwama, Takehisa
;
Asakura, Yumiko
...
European Journal of Pharmacology. 618 (2009) 1-3 - p. 63-69 , 2009
Link:
https://doi.org/10.1016/..
?
8
NT-702 (parogrelil hydrochloride, NM-702), a novel and pote..:
Ishiwata, Norihisa
;
Noguchi, Kazuo
;
Kawanishi, Masafumi
...
Life Sciences. 81 (2007) 12 - p. 970-978 , 2007
Link:
https://doi.org/10.1016/..
?
9
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:
Takeuchi, Tsutomu
;
Chino, Yukihiro
;
Kawanishi, Masafumi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099673/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
Phase II/III Results of a Trial of Anti–Tumor Necrosis Fact..:
Takeuchi, Tsutomu
;
Kawanishi, Masafumi
;
Nakanishi, Megumi
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828347/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:
Tsutomu Takeuchi
;
Yukihiro Chino
;
Masafumi Kawanishi
...
https://doi.org/10.1186/s13075-023-03036-4. , 2023
Link:
https://doi.org/10.1186/..
?
12
Myonectin protects against skeletal muscle dysfunction in m..:
Ozaki, Yuta
;
Ohashi, Koji
;
Otaka, Naoya
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
13
Indications for Percutaneous Drainage in Patients with Huan..:
Fukunaga, Shohei
;
Naito, Yumi
;
Hoshino, Yuki
...
Internal Medicine. 62 (2023) 19 - p. 2871-2876 , 2023
Link:
https://doi.org/10.2169/..
?
14
Utility of renal biopsy in differentiating idiopathic multi..:
Kawanishi, Miharu
;
Kamei, Fumika
;
Sonoda, Hirotaka
...
CEN Case Reports. 12 (2022) 2 - p. 242-248 , 2022
Link:
https://doi.org/10.1007/..
?
15
Effectiveness of CKD Exacerbation Countermeasures in Izumo ..:
Ito, Takafumi
;
Kamei, Fumika
;
Sonoda, Hirotaka
...
Journal of Personalized Medicine. 11 (2021) 11 - p. 1104 , 2021
Link:
https://doi.org/10.3390/..
1-15